Class IITerminatedD-1064-2020
Drug recall · March 25, 2020
Sodium Chloride 0.9% Injection recall
Why: CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451
- Lots / codes
Lot #: 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020
- Quantity
- 32,592 bags
- Company
- Fresenius Medical Care Holdings, Inc., Waltham, MA
- Distribution
- Product was distributed throughout the United States.
- Initiated
- March 5, 2020 · Voluntary: Firm initiated
- Classified
- March 26, 2020
- Reported
- March 25, 2020
- Ended
- February 3, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.